The Effect of K-ATP Channel Blockage During Erythropoietin Treatment in Renal Ischemia-Reperfusion Injury

REFERENCES

• Li C, Jackson R M. Reactive species mechanisms of cellular hypoxiareoxygenation injury. Am J Physiol Cell Physiol 2002; 282: 227–241
   PubMed Web of Science ®Google Scholar
• Bonventre J V. Pathophysiology of acute kidney injury: roles of potential inhibitors of inflammation. Contrib Nephrol 2007; 156: 39–46
   PubMed Web of Science ®Google Scholar
• Padanilam B J. Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis. Am J Physiol Renal Physiol 2003; 284: 608–627
   PubMed Web of Science ®Google Scholar
• Gobe G, Willgoss D, Hogg N, et al. Cell survival or death in renal tubular epithelium after ischemia-reperfusion injury. Kidney Int 1999; 56: 1299–1304
   PubMed Web of Science ®Google Scholar
• Ghezzi P, Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 2004; 11: 37–44
   PubMed Web of Science ®Google Scholar
• Brines M, Cerami A. Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. Kidney Int 2006; 70: 246–250
   PubMed Web of Science ®Google Scholar
• Sun Y, Calvert J W, Zhang J H. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 2005; 36: 1672–1678
   PubMed Web of Science ®Google Scholar
• Kumral A, Gonenc S, Acikgoz O, et al. Erythropoietin increases glutathione peroxidase enzyme activity and decreases lipid peroxidation levels in hypoxic-ischemic brain injury in neonatal rats. Biol Neonate 2005; 87: 15–18
   PubMedGoogle Scholar
• Sharples E J, Yaqoob M M. Erythropoietin in experimental acute renal failure. Nephron Exp Nephrol 2006; 104: 83–88
   PubMed Web of Science ®Google Scholar
• Joyeux-Faure M, Ramond A, Beguin P C, et al. Early pharmacological preconditioning by erythropoietin mediated by inducible NOS and mitochondrial ATP-dependent potassium channels in the rat heart. Fundam Clin Pharmacol 2006; 20: 51–56
   PubMed Web of Science ®Google Scholar
• Shi Y P, Rafiee J, Su J, et al. Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels. Basic Res Cardiol 2004; 99: 173–182
   PubMed Web of Science ®Google Scholar
• Hanlon P R, Fu P, Wright G L, et al. Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling. FASEB J 2005; 19: 1323–1325
   PubMed Web of Science ®Google Scholar
• Imamura R, Moriyama T, Isaka Y, et al. Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1alpha. Transplantation 2007; 27(83)1371–1379
   Google Scholar
• Spandou E, Tsouchnikas I, Karkavelas G, et al. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrol Dial Transplant 2006; 21: 330–336
   PubMed Web of Science ®Google Scholar
• Yang C W, Li C, Jung J Y, et al. Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J 2003; 17: 1754–1755
   PubMed Web of Science ®Google Scholar
• Vesey D A, Cheung C, Pat B, et al. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 2004; 19: 348–355
   PubMed Web of Science ®Google Scholar
• Rafiee P, Shi Y, Su J, et al. Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways. Basic Res Cardiol 2005; 100: 187–197
   PubMed Web of Science ®Google Scholar
• Chatterjee P K, Cuzzocrea S, Brown P A, et al. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int 2000; 58: 658–673
   PubMed Web of Science ®Google Scholar
• Halestrap A P, Doran E, Gillespie J P, et al. Mitochondria and cell death. Biochem Soc Trans 2000; 28: 170–177
   PubMed Web of Science ®Google Scholar
• Tang X D, Santarelli L C, Heinemann S H, et al. Metabolic regulation of potassium channels. Annu Rev Physiol 2004; 66: 131–159
   PubMed Web of Science ®Google Scholar
• Sun Z, Zhang X, Ito K, et al. Amelioration of oxidative mitochondrial DNA damage and deletion after renal ischemic injury by the KATP channel opener diazoxide. Am J Physiol Renal Physiol 2008; 294: 491–498
   Web of Science ®Google Scholar
• Cuong D V, Kim N, Youm J B, et al. Nitric oxide-cGMP-protein kinase G signaling pathway induces anoxic preconditioning through activation of ATP-sensitive K+ channels in rat hearts. Am J Physiol Heart Circ Physiol 2006; 290: 1808–1817
   Web of Science ®Google Scholar
• Chrissobolis S, Sobey C G. Inwardly rectifying potassium channels in the regulation of vascular tone. Curr Drug Targets 2003; 4: 281–289
   PubMed Web of Science ®Google Scholar
• Qiu M R, Campbell T J, Breit S N. A potassium ion channel is involved in cytokine production by activated human macrophages. Clin Exp Immunol 2002; 130: 67–74
   PubMed Web of Science ®Google Scholar
• Okouchi M, Okayama N, Omi H, et al. The antidiabetic agent, gliclazide, reduces high insulin-enhanced neutrophil-transendothelial migration through direct effects on the endothelium. Diabetes Metab Res Rev 2004; 20: 232–238
   PubMed Web of Science ®Google Scholar
• Toledo-Pereyra L H, Lopez-Neblina F, Toledo A H. Reactive oxygen species and molecular biology of ischemia/reperfusion. Ann Transplant 2004; 9: 81–83
   PubMedGoogle Scholar
• Pompermayer K, Souza D G, Lara G G, et al. The ATP-sensitive potassium channel blocker glibenclamide prevents renal ischemia/reperfusion injury in rats. Kidney Int 2005; 67: 1785–1796
   PubMed Web of Science ®Google Scholar
• Zingman L V, Alekseev A E, Hodgson-Zingman D M, et al. ATP-sensitive potassium channels: metabolic sensing and cardioprotection. J Appl Physiol 2007; 103(5)1888–1893
   PubMed Web of Science ®Google Scholar
• Takashi E, Wang Y, Ashraf M. Activation of mitochondrial K(ATP) channel elicits late preconditioning against myocardial infarction via protein kinase C signaling pathway. Circ Res 1999; 3–17(12)1146–1153, 85
   Google Scholar
• Von Lindern M, Parren-Von Amehvort M, Von Dijk T, et al. Protein kinase c controls erythropoietin receptor signaling. J Biol Chem 2000; 275: 34719–34727
   PubMed Web of Science ®Google Scholar
• Kanagy N L, Perrine M F, Cheung D K, et al. Erythropoietin administration in vivo increases vascular nitric oxide synthase expression. J Cardiovasc Pharmacol 2003; 42(4)527
   PubMed Web of Science ®Google Scholar
• Gong H, Wang W, Kwon T H, et al. EPO and alpha-MSH prevent ischemia/reperfusion-induced downregulation of AQPs and sodium transporters in rat kidney. Kidney Int 2004; 66: 683–695
   PubMed Web of Science ®Google Scholar